First report of clinical response to venetoclax combination with pentostatin in T-cell-prolymphocytic leukemia (T-PLL)

Mansour Alfayez; Beenu Thakral; Preetesh Jain; Farhad Ravandi; Alessandra Ferrajoli; Nitin Jain; Naveen Pemmaraju; William Wierda; Tapan Kadia

doi:10.1080/10428194.2019.1660967

First report of clinical response to venetoclax combination with pentostatin in T-cell-prolymphocytic leukemia (T-PLL)

Mansour Alfayez, Beenu Thakral, Preetesh Jain, Farhad Ravandi, Alessandra Ferrajoli, Nitin Jain, Naveen Pemmaraju, William Wierda, Tapan Kadia

Research output: Contribution to journal › Letter › peer-review

10 Scopus citations

Original language	English (US)
Pages (from-to)	445-449
Number of pages	5
Journal	Leukemia and Lymphoma
Volume	61
Issue number	2
DOIs	https://doi.org/10.1080/10428194.2019.1660967
State	Published - Jan 28 2020

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

Access to Document

10.1080/10428194.2019.1660967

Cite this

@article{f082a1f5ef0544b1a2043dbf4c37ea9c,

title = "First report of clinical response to venetoclax combination with pentostatin in T-cell-prolymphocytic leukemia (T-PLL)",

author = "Mansour Alfayez and Beenu Thakral and Preetesh Jain and Farhad Ravandi and Alessandra Ferrajoli and Nitin Jain and Naveen Pemmaraju and William Wierda and Tapan Kadia",

note = "Funding Information: This study was supported in part by the MD Anderson Cancer Center Support Grant (CCSG) CA016672, the MD Anderson Cancer Center Leukemia SPORE CA100632, the Charif Souki Cancer Research Fund and generous philanthropic contributions to the MD Anderson Moon Shots Program. Copyright: Copyright 2020 Elsevier B.V., All rights reserved.",

year = "2020",

month = jan,

day = "28",

doi = "10.1080/10428194.2019.1660967",

language = "English (US)",

volume = "61",

pages = "445--449",

journal = "Leukemia and Lymphoma",

issn = "1042-8194",

publisher = "Informa Healthcare",

number = "2",

}

TY - JOUR

T1 - First report of clinical response to venetoclax combination with pentostatin in T-cell-prolymphocytic leukemia (T-PLL)

AU - Alfayez, Mansour

AU - Thakral, Beenu

AU - Jain, Preetesh

AU - Ravandi, Farhad

AU - Ferrajoli, Alessandra

AU - Jain, Nitin

AU - Pemmaraju, Naveen

AU - Wierda, William

AU - Kadia, Tapan

N1 - Funding Information: This study was supported in part by the MD Anderson Cancer Center Support Grant (CCSG) CA016672, the MD Anderson Cancer Center Leukemia SPORE CA100632, the Charif Souki Cancer Research Fund and generous philanthropic contributions to the MD Anderson Moon Shots Program. Copyright: Copyright 2020 Elsevier B.V., All rights reserved.

PY - 2020/1/28

Y1 - 2020/1/28

UR - http://www.scopus.com/inward/record.url?scp=85073938767&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85073938767&partnerID=8YFLogxK

U2 - 10.1080/10428194.2019.1660967

DO - 10.1080/10428194.2019.1660967

M3 - Letter

C2 - 31566032

AN - SCOPUS:85073938767

SN - 1042-8194

VL - 61

SP - 445

EP - 449

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

IS - 2

ER -

First report of clinical response to venetoclax combination with pentostatin in T-cell-prolymphocytic leukemia (T-PLL)

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this